Breaking News, Promotions & Moves

Cube Biotech Appoints Michael Bencak Chief Executive Officer

Current CEO Didier Dargent will transition to Executive Chairman.

By: Rachel Klemovitch

Assistant Editor

Cube Biotech, an innovator in protein stabilization and purification technologies, announced a leadership transition to continue global growth. Didier Dargent, who has served as Chief Executive Officer, will transition into the role of Executive Chairman. Michael Bencak has been appointed as the new CEO of Cube Biotech and IBA Lifescience, effective immediately.  Bencak joins Cube Biotech with a track record of leading biotech organizations through growth, transformation, and innovation. With...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters